ZBH
Zimmer Biomet Holdings Inc

1,294
Mkt Cap
$20.43B
Volume
471.00
52W High
$114.72
52W Low
$89.22
PE Ratio
25.11
ZBH Fundamentals
Price
$103.12
Prev Close
$103.03
Open
$103.15
50D MA
$101.80
Beta
0.51
Avg. Volume
1.39M
EPS (Annual)
$4.43
P/B
1.63
Rev/Employee
$451,682.35
Loading...
Loading...
News
all
press releases
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System Zimmer Biomet Announces FDA Breakthrough Designation for World's First...
PR Newswire·46m ago
News Placeholder
More News
News Placeholder
Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?
GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.
Zacks·23h ago
News Placeholder
Will Zimmer (ZBH) Beat Estimates Again in Its Next Earnings Report?
Zimmer (ZBH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·5d ago
News Placeholder
Elevance Health Q3 Earnings Beat Estimates on Strong MA Membership
ELV beats EPS estimates by 21% in Q3 as strong Medicare Advantage membership gains and Carelon revenue growth offset Medicaid losses.
Zacks·7d ago
News Placeholder
Will ISRG's dV5 Lend Momentum to Top Line During Q3 Earnings?
Intuitive Surgical's new da Vinci 5 is driving strong hospital upgrades and premium pricing, setting up ISRG for potential top-line momentum in Q3.
Zacks·7d ago
News Placeholder
Zimmer Biomet to Report Q3 Earnings: Here's What to Expect
ZBH's Q3 results on Nov. 5 may show solid gains, driven by hip, knee, and S.E.T. segment growth and recent product approvals.
Zacks·7d ago
News Placeholder
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual...
PR Newswire·7d ago
News Placeholder
The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock
Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches.
Zacks·18d ago
News Placeholder
Are Investors Undervaluing Zimmer Biomet (ZBH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·25d ago
News Placeholder
ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7
Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.
Zacks·26d ago

Latest ZBH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.